Published in Heart Lung on July 18, 1977
Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med (1974) 3.33
Assessing quality of care from the medical record. N Engl J Med (1972) 2.93
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14
Myopathy of hypothyroidism. Ann Rheum Dis (1968) 1.81
Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea. Gastroenterology (1995) 1.51
Renal outcomes of gout and hyperuricemia. Am J Med (1979) 1.46
ANA-negative systemic lupus erythematosus. Am J Med (1978) 1.36
Idiopathic hypertrophic osteoarthropathy (pachydermoperiostosis). West J Med (1981) 1.29
Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial. Curr Med Res Opin (2005) 1.24
Megadose corticosteroid therapy in systemic lupus erythematosus. J Rheumatol (1980) 1.21
Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clin Infect Dis (1998) 1.10
Rheumatic manifestations of hypophosphatemia. Arch Intern Med (1974) 1.07
Cryptococcal meningitis after unusual exposures to birds. N Engl J Med (1993) 1.02
Correlates and consequences of asymptomatic hyperuricemia. Arch Intern Med (1973) 1.01
High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med (1980) 0.95
Hyperuricemia in health and disease. Semin Arthritis Rheum (1972) 0.94
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial. J Infect Dis (2000) 0.93
Autoimmunity in the pathogenesis of muscle disease. Neurology (1968) 0.92
Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068. Antivir Ther (1996) 0.89
Myalgia and bird-keeping. Lancet (1970) 0.89
Thalidomide for the treatment of AIDS-associated wasting. AIDS Res Hum Retroviruses (2000) 0.89
Angiographic demonstration of major cerebral vessel occlusion in systemic lupus erythematosus. Neuroradiology (1972) 0.89
Medical record as index of quality of care. N Engl J Med (1972) 0.87
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients. AIDS Res Hum Retroviruses (1999) 0.86
Fat disorders and peripheral neuropathy. Brain (1971) 0.85
Strategic aspects of prescription writing. Postgrad Med (1981) 0.84
Atheromatous microembolism simulating polymyositis. JAMA (1968) 0.82
Polymyalgia rheumatica, temporal arteritis, and contact with birds. Lancet (1969) 0.81
The nature of illness and diagnosis. Am J Med (1983) 0.81
Letter: HL-A 27 (W27) absent in gonococcal arthritis. Lancet (1975) 0.80
Polymyalgia rheumatica and blindness. N Engl J Med (1967) 0.79
Genetic and stress factors affecting the abnormal lymphocyte in schizophrenia. J Psychiatr Res (1965) 0.78
Scleroderma and welding. N Engl J Med (1977) 0.77
Globulins and behavior in schizophrenia. Int J Neuropsychiatry (1966) 0.76
Salvage therapy and formulation of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 0.75
Early treatment of HIV infection. N Engl J Med (1995) 0.75
Viral load and response to treatment of HIV. N Engl J Med (1996) 0.75
Muscle diseases in rheumatology. Semin Arthritis Rheum (1973) 0.75
Immunologic reactivity in hyperuricemia. N Engl J Med (1972) 0.75
Letter: Rheumatology for clinicians. N Engl J Med (1976) 0.75
Uric acid, lean body weight, and creatinine interactions: results from regression analysis of 78 variables. Semin Arthritis Rheum (1977) 0.75
Remote effects of benign neoplasms. N Engl J Med (1973) 0.75
Mixed connective-tissue disease. N Engl J Med (1977) 0.75
Distinguishing gout from other types of arthritis. Postgrad Med (1978) 0.75
Systemic lupus erythematosus as seen in primary care. Postgrad Med (1979) 0.75
Pathogenesis of diabetic and alcoholic neuropathy. N Engl J Med (1971) 0.75
Reversal of azotemia in lupus nephritis by megadose corticosteroid therapy. Arthritis Rheum (1977) 0.75
Megestrol acetate and hyperpnea. Ann Intern Med (1989) 0.75